Utah’s Medical Cannabis Policy Advisory Board will meet October 20 to review proposed regulatory changes and legislative recommendations that could shape the state’s medical marijuana program.
According to the official meeting agenda, the board will hear a presentation on draft rules from the state’s Specialized Product Authority Licensing Board, followed by a 45-minute discussion of legislative recommendations developed by the advisory board’s Industry Committee.
The meeting is scheduled to begin at 2 p.m. Mountain Time, with the draft rules presentation set for 2:45 p.m. and the legislative recommendations beginning at 3:15 p.m.
The Industry Committee has been developing policy priorities for several months. During the board’s September 15 meeting, members discussed a proposal to extend the default validity period of medical marijuana patient cards from two years to five years.
According to the September meeting minutes, board members considered whether longer registration periods should apply to patients with incurable or chronic conditions, whether providers should have greater discretion over card durations, and whether different standards should apply to adults and minors.
Members also discussed potential safeguards, including requirements for in-person medical evaluations. During that discussion, board member J.D. Lauritzen clarified that changing the statutory requirements governing card durations would require legislative action.
An earlier version of the October 20 agenda specifically identified extending patient card durations as an Industry Committee presentation topic. The updated agenda instead lists the broader category of legislative recommendations, without specifying which proposals will be presented.
The advisory board, established by lawmakers in 2023, is authorized to recommend changes to medical marijuana regulations and statutes, including recommendations to the Utah Department of Agriculture and Food and legislative committees. Its recommendations do not independently change state law.
The October 20 meeting will also include updates from the board’s Patient Access, Industry, Research and Education, and Policy and Rules committees.
The meeting will take place at the Taylorsville State Office Building, 4315 S. 2700 W., in Room 2507. Members of the public can also attend virtually using webinar ID 817 5849 0365.
